• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子三联体 - 内脏脂肪素、胎盘生长因子和 fractalkine - 及其在非阻塞性冠状动脉心肌梗死(MINOCA)中的作用。

The cytokine trio - visfatin, placental growth factor and fractalkine - and their role in myocardial infarction with non-obstructive coronary arteries (MINOCA).

机构信息

Department of Human Physiology and Pathophysiology, Faculty of Medicine, Collegium Medicum Cardinal Stefan Wyszynski University in Warsaw, Wóycickiego 1/3, 01-938 Warsaw, Poland; College of Medical Sciences, Nicolaus Copernicus Superior School, Nowogrodzka 47a, 00-695 Warsaw, Poland.

First Department of Cardiology, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland.

出版信息

Cytokine Growth Factor Rev. 2023 Dec;74:76-85. doi: 10.1016/j.cytogfr.2023.08.009. Epub 2023 Aug 25.

DOI:10.1016/j.cytogfr.2023.08.009
PMID:37679252
Abstract

Myocardial infarction with nonobstructive coronary arteries (MINOCA) remains a puzzling clinical entity. It is characterized by clinical evidence of myocardial infarction (MI) with normal or near-normal coronary arteries in angiography. Given the complex etiology including multiple possible scenarios with varied pathogenetic mechanisms, profound investigation of the plausible biomarkers of MINOCA may bring further pathophysiological insights and novel diagnostic opportunities. Cytokines have a great diagnostic potential and are used as biomarkers for many diseases. An unusual trio of visfatin, placental growth factor (PlGF) and fractalkine (CX3CL1) can directly promote vascular dysfunction, inflammation and angiogenesis through the activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling. They are redundant in physiological processes and become overexpressed in the pathomechanisms underlying MINOCA. The knowledge about their concentration might serve as a valuable diagnostic and/or therapeutic tool for assessing vascular endothelial function. Here we analyze the current knowledge on visfatin, PlGF and CX3CL1 in the context of MINOCA and present the novel clinical implications of their combined expression as predictors or indicators of this condition.

摘要

非阻塞性冠状动脉心肌梗死(MINOCA)仍然是一个令人费解的临床实体。其特征是在血管造影中存在心肌梗死(MI)的临床证据,但冠状动脉正常或接近正常。鉴于包括多种可能的发病机制的复杂病因,深入研究 MINOCA 的可能生物标志物可能会带来进一步的病理生理学见解和新的诊断机会。细胞因子具有很大的诊断潜力,并且被用作许多疾病的生物标志物。不寻常的三联体内脏脂肪素、胎盘生长因子(PlGF)和 fractalkine(CX3CL1)可以通过核因子 kappa-轻链增强子的激活直接促进血管功能障碍、炎症和血管生成B 细胞(NF-κB)信号。它们在生理过程中是冗余的,在 MINOCA 发病机制中过度表达。关于它们浓度的知识可能是评估血管内皮功能的有价值的诊断和/或治疗工具。在这里,我们分析了内脏脂肪素、PlGF 和 CX3CL1 在 MINOCA 背景下的现有知识,并提出了它们联合表达作为该疾病预测因子或标志物的新的临床意义。

相似文献

1
The cytokine trio - visfatin, placental growth factor and fractalkine - and their role in myocardial infarction with non-obstructive coronary arteries (MINOCA).细胞因子三联体 - 内脏脂肪素、胎盘生长因子和 fractalkine - 及其在非阻塞性冠状动脉心肌梗死(MINOCA)中的作用。
Cytokine Growth Factor Rev. 2023 Dec;74:76-85. doi: 10.1016/j.cytogfr.2023.08.009. Epub 2023 Aug 25.
2
Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): A Review of the Current Position.非阻塞性冠状动脉心肌梗死(MINOCA):当前状况综述。
Cardiology. 2020;145(9):543-552. doi: 10.1159/000509100. Epub 2020 Aug 4.
3
Myocardial infarction with nonobstructive coronary arteries: from pathophysiology to therapeutic strategies.非阻塞性冠状动脉所致心肌梗死:从病理生理学到治疗策略
J Cardiovasc Med (Hagerstown). 2023 May 1;24(Suppl 2):e134-e146. doi: 10.2459/JCM.0000000000001439.
4
Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial.心肌梗死伴非阻塞性与阻塞性冠状动脉患者的生物标志物浓度及其时间变化:来自 PLATO 试验的结果。
J Am Heart Assoc. 2023 Jan 3;12(1):e027466. doi: 10.1161/JAHA.122.027466. Epub 2022 Dec 24.
5
Myocardial infarction with nonobstructive coronary arteries: the need for precision medicine.非阻塞性冠状动脉心肌梗死:精准医学的需求。
Curr Opin Cardiol. 2022 Nov 1;37(6):481-487. doi: 10.1097/HCO.0000000000000998. Epub 2022 Sep 12.
6
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries.非阻塞性冠状动脉病变心肌梗死后 3 个月患者炎症活性增加。
Clin Chem. 2019 Aug;65(8):1023-1030. doi: 10.1373/clinchem.2018.301085. Epub 2019 May 9.
7
Myocardial Infarction with Nonobstructive Coronary Arteries.非阻塞性冠状动脉所致心肌梗死
Annu Rev Med. 2023 Jan 27;74:171-188. doi: 10.1146/annurev-med-042921-111727. Epub 2022 Sep 30.
8
Myocardial infarction with non-obstructive coronary arteries: Etiology, diagnosis, treatment and prognosis.非阻塞性冠状动脉心肌梗死:病因、诊断、治疗和预后。
Rev Port Cardiol. 2023 Jul;42(7):655-666. doi: 10.1016/j.repc.2022.10.007. Epub 2023 Mar 10.
9
Precision medicine in Myocardial Infarction With Non-obstructive Coronary Disease (MINOCA): A comprehensive review.精准医学在非阻塞性冠状动脉疾病心肌梗死中的应用(MINOCA):全面综述。
Curr Probl Cardiol. 2024 Feb;49(2):102185. doi: 10.1016/j.cpcardiol.2023.102185. Epub 2023 Nov 2.
10
Coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteries: Where do we stand?冠状动脉微血管功能障碍与非阻塞性冠状动脉心肌梗死:我们目前的进展如何?
Eur J Intern Med. 2023 Nov;117:8-20. doi: 10.1016/j.ejim.2023.07.016. Epub 2023 Jul 22.

引用本文的文献

1
Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.新型心脏生物标志物及多标志物方法在心脏病早期检测、预后评估及风险分层中的应用
World J Cardiol. 2025 Jul 26;17(7):106561. doi: 10.4330/wjc.v17.i7.106561.
2
The Relationship Between Advanced Lung Cancer Inflammation Index and Adverse Clinical Outcomes in Patients with Myocardial Infarction with No-Obstructive Coronary Arteries.无阻塞性冠状动脉心肌梗死患者中晚期肺癌炎症指数与不良临床结局的关系
J Inflamm Res. 2025 Jul 26;18:9907-9917. doi: 10.2147/JIR.S531821. eCollection 2025.
3
Molecular screening in a translational large animal trial identifies a differential inflammatory response for MINOCA.
在一项转化性大型动物试验中的分子筛查确定了心肌梗死伴非阻塞性冠状动脉病变(MINOCA)的不同炎症反应。
Basic Res Cardiol. 2025 Jun 13. doi: 10.1007/s00395-025-01118-9.
4
Myocardial infarction with nonobstructive coronary arteries (MINOCA): a narrative review.非阻塞性冠状动脉心肌梗死(MINOCA):一篇叙述性综述。
Eur J Med Res. 2025 Jun 2;30(1):443. doi: 10.1186/s40001-025-02703-3.
5
Developments in Extracellular Matrix-Based Angiogenesis Therapy for Ischemic Heart Disease: A Review of Current Strategies, Methodologies and Future Directions.基于细胞外基质的缺血性心脏病血管生成疗法的进展:当前策略、方法及未来方向综述
BioTech (Basel). 2025 Mar 19;14(1):23. doi: 10.3390/biotech14010023.
6
Prognostic Value of Systemic Inflammation Response Index and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries- A Retrospective Study.全身炎症反应指数和N端前B型利钠肽在非阻塞性冠状动脉心肌梗死患者中的预后价值——一项回顾性研究
J Inflamm Res. 2024 Nov 6;17:8281-8298. doi: 10.2147/JIR.S482596. eCollection 2024.
7
Alterations in CX3CL1 Levels and Its Role in Viral Pathogenesis.CX3CL1水平的改变及其在病毒致病机制中的作用。
Int J Mol Sci. 2024 Apr 18;25(8):4451. doi: 10.3390/ijms25084451.
8
Chemokine Fractalkine and Non-Obstructive Coronary Artery Disease-Is There a Link?趋化因子 fractalkine 与非阻塞性冠状动脉疾病有关吗?
Int J Mol Sci. 2024 Mar 30;25(7):3885. doi: 10.3390/ijms25073885.
9
Pro-Inflammatory Biomarkers and Progression of Atherosclerosis in Patients with Myocardial Infarction with Non-Obstructive Coronary Artery Disease: 1-Year Follow-Up.促炎生物标志物与非阻塞性冠状动脉疾病心肌梗死患者动脉粥样硬化进展:1年随访
J Pers Med. 2023 Nov 29;13(12):1669. doi: 10.3390/jpm13121669.